A central role for mTOR in Determining T Cell Activation versus Tolerance

mTOR 在确定 T 细胞激活与耐受性方面的核心作用

基本信息

  • 批准号:
    8277329
  • 负责人:
  • 金额:
    $ 40.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-06-15 至 2014-05-31
  • 项目状态:
    已结题

项目摘要

The outcome of TCR recognition is dictated by the context in which the antigen is recognized. While TCR engagement (Signal 1) heralds recognition, whether this recognition will lead to an immunogenic response is dictated by the presence of costimulatory molecules (Signal 2) on the APC. Furthermore, cytokines such as IL-12, IFN-¿, IL-4, IL-6 and TGF-¿ in the inflammatory milieu play critical roles in skewing T cell differentiation. Based on these environmental cues T cells may differentiate into effector subsets characterized by TH1, TH2 and TH17 cells or regulatory cells characterized by Foxp3 expression, LAG-3 expression and IL-10 secretion. We propose that the highly evolutionarily conserved threonine/serine protein kinase the mammalian Target of Rapamycin (mTOR) plays a critical role in integrating these cues and dictating the outcome of antigen recognition. In an effort to understand the mechanisms and pathways by which mTOR regulates T cell function we generated conditional mTOR knockout mice in T cells. mTOR deficient T cells develop normally and produce normal levels of IL-2 upon initial stimulation. However, TCR engagement in the absence of mTOR renders such cells anergic, as revealed by a failure to produce IL-2 and IFN-¿. Furthermore, mTOR deficient T cells fail to differentiate into TH1,TH2 or TH17 effector cells. Instead, under normally activating conditions, both in vitro and in vivo these cells develop into regulatory T cells. In this proposal we will employ mTOR null, Rheb null, Rictor null and TSC2 null T cells to determine the role of TORC1 and TORC2 in regulating T cell activation and adaptive effector versus regulatory lineage commitment. Using in vivo models of tumor immunity, viral infection, allergen, EAE and bone marrow transplantation we will further determine the role of mTOR and its downstream signaling in regulating immune responses. Our approach will have important implications with regard to the rationale design of immunosuppressive agents for the treatment of autoimmune disorders and organ transplantation as well as devising strategies to enhance anti-tumor immunity.
TCR识别的结果取决于抗原所在的环境

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JONATHAN D POWELL其他文献

JONATHAN D POWELL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JONATHAN D POWELL', 18)}}的其他基金

Project 2: Interrogating immuno-metabolic programs using a novel Flow Cytometry based  assay to reveal novel T cell subsets in SARS-CoV-2 infected patients
项目 2:使用新型流式细胞术检测免疫代谢程序,揭示 SARS-CoV-2 感染患者中的新型 T 细胞亚群
  • 批准号:
    10688365
  • 财政年份:
    2020
  • 资助金额:
    $ 40.18万
  • 项目类别:
Project 2: Interrogating immuno-metabolic programs using a novel Flow Cytometry based  assay to reveal novel T cell subsets in SARS-CoV-2 infected patients
项目 2:使用新型流式细胞术检测免疫代谢程序,揭示 SARS-CoV-2 感染患者中的新型 T 细胞亚群
  • 批准号:
    10221909
  • 财政年份:
    2020
  • 资助金额:
    $ 40.18万
  • 项目类别:
TR&D3: Metabolic Programming
TR
  • 批准号:
    10436872
  • 财政年份:
    2019
  • 资助金额:
    $ 40.18万
  • 项目类别:
TR&D3: Metabolic Programming
TR
  • 批准号:
    10223295
  • 财政年份:
    2019
  • 资助金额:
    $ 40.18万
  • 项目类别:
TR&D3: Metabolic Programming
TR
  • 批准号:
    10645131
  • 财政年份:
    2019
  • 资助金额:
    $ 40.18万
  • 项目类别:
TR&D3: Metabolic Programming
TR
  • 批准号:
    9790439
  • 财政年份:
    2019
  • 资助金额:
    $ 40.18万
  • 项目类别:
Transplantation tolerance and immune function following mTOR inhibition.
mTOR 抑制后的移植耐受和免疫功能。
  • 批准号:
    8519045
  • 财政年份:
    2010
  • 资助金额:
    $ 40.18万
  • 项目类别:
Transplantation tolerance and immune function following mTOR inhibition.
mTOR 抑制后的移植耐受和免疫功能。
  • 批准号:
    8318280
  • 财政年份:
    2010
  • 资助金额:
    $ 40.18万
  • 项目类别:
Transplantation tolerance and immune function following mTOR inhibition.
mTOR 抑制后的移植耐受和免疫功能。
  • 批准号:
    8013240
  • 财政年份:
    2010
  • 资助金额:
    $ 40.18万
  • 项目类别:
Transplantation tolerance and immune function following mTOR inhibition.
mTOR 抑制后的移植耐受和免疫功能。
  • 批准号:
    8144889
  • 财政年份:
    2010
  • 资助金额:
    $ 40.18万
  • 项目类别:

相似海外基金

The early-life mycobiome as a determinant of oral tolerance to food allergens
生命早期的真菌组是食物过敏原口腔耐受性的决定因素
  • 批准号:
    498187
  • 财政年份:
    2023
  • 资助金额:
    $ 40.18万
  • 项目类别:
    Operating Grants
Quantitative risk assessment of unintended allergens in school-provided lunch and food service at nursery.
对学校提供的午餐和托儿所食品服务中的意外过敏原进行定量风险评估。
  • 批准号:
    23K07902
  • 财政年份:
    2023
  • 资助金额:
    $ 40.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Reassessment of the diversity and commonality of food allergens using transdermal sensitization capacity and digestive resistance as indicators.
以透皮致敏能力和消化阻力为指标重新评估食物过敏原的多样性和共性。
  • 批准号:
    23K05103
  • 财政年份:
    2023
  • 资助金额:
    $ 40.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of analysis techniques for precise epitopes of food allergens
食品过敏原精确表位分析技术的开发
  • 批准号:
    23K17976
  • 财政年份:
    2023
  • 资助金额:
    $ 40.18万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Discovering epitope mimics (mimitopes) of chemical allergens that cause occupational asthma
发现导致职业性哮喘的化学过敏原的模拟表位(模拟表位)
  • 批准号:
    10741979
  • 财政年份:
    2023
  • 资助金额:
    $ 40.18万
  • 项目类别:
Age-Related Alterations in Neuro-Immune Recognition of Allergens
过敏原神经免疫识别中与年龄相关的变化
  • 批准号:
    10373431
  • 财政年份:
    2022
  • 资助金额:
    $ 40.18万
  • 项目类别:
Do allergens contribute to neurodegeneration?
过敏原会导致神经退行性变吗?
  • 批准号:
    10542643
  • 财政年份:
    2022
  • 资助金额:
    $ 40.18万
  • 项目类别:
Age-Related Alterations in Neuro-Immune Recognition of Allergens
过敏原神经免疫识别中与年龄相关的变化
  • 批准号:
    10559576
  • 财政年份:
    2022
  • 资助金额:
    $ 40.18万
  • 项目类别:
Do allergens contribute to neurodegeneration?
过敏原会导致神经退行性变吗?
  • 批准号:
    10190052
  • 财政年份:
    2021
  • 资助金额:
    $ 40.18万
  • 项目类别:
Lateral flow array for undeclared food allergens
用于未申报食物过敏原的侧流阵列
  • 批准号:
    10320285
  • 财政年份:
    2021
  • 资助金额:
    $ 40.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了